These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 8531897)
1. 131I MIBG/111In octreotide mismatch in a patient with liver metastases secondary to a carcinoid of unknown origin. Orsolon P; Bagni B Minerva Endocrinol; 1995 Jun; 20(2):145-7. PubMed ID: 8531897 [TBL] [Abstract][Full Text] [Related]
2. [111IN-octreotide and 123I-MIBG scintigraphy in the diagnosis of small intestinal carcinoid tumors--results of a comparative investigation]. Dresel S; Tatsch K; Zachoval R; Hahn K Nuklearmedizin; 1996 Apr; 35(2):53-8. PubMed ID: 8721576 [TBL] [Abstract][Full Text] [Related]
3. Successful and unsuccessful approaches to imaging carcinoids: comparison of a radiolabelled tryptophan hydroxylase inhibitor with a tracer of biogenic amine uptake and storage, and a somatostatin analogue. Macfarlane D; Gonin J; Wieland D; Mangner T; Froelich J; Beierwaltes W; Shapiro B Eur J Nucl Med; 1996 Feb; 23(2):131-40. PubMed ID: 8925846 [TBL] [Abstract][Full Text] [Related]
4. Combined diagnostic imaging with 131I-metaiodobenzylguanidine and 111In-pentetreotide in carcinoid tumours. Taal BG; Hoefnagel CA; Valdés Olmos RA; Boot H Eur J Cancer; 1996 Oct; 32A(11):1924-32. PubMed ID: 8943676 [TBL] [Abstract][Full Text] [Related]
5. Imaging secondary neuroendocrine tumours of the liver: comparison of I123 metaiodobenzylguanidine (MIBG) and In111-labelled octreotide (Octreoscan). Ramage JK; Williams R; Buxton-Thomas M QJM; 1996 Jul; 89(7):539-42. PubMed ID: 8759495 [TBL] [Abstract][Full Text] [Related]
6. Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma. Tenenbaum F; Lumbroso J; Schlumberger M; Mure A; Plouin PF; Caillou B; Parmentier C J Nucl Med; 1995 Jan; 36(1):1-6. PubMed ID: 7799058 [TBL] [Abstract][Full Text] [Related]
7. Comparison of somatostatin analogue and metaiodobenzylguanidine scintigraphy for the detection of carcinoid tumours. Nocaudie-Calzada M; Huglo D; Carnaille B; Proye C; Marchandise X Eur J Nucl Med; 1996 Nov; 23(11):1448-54. PubMed ID: 8854840 [TBL] [Abstract][Full Text] [Related]
8. Scintiscans and carcinoid tumors. Carnaille B; Nocaudie M; Pattou F; Huglo D; Deveaux M; Marchandise X; Proye C Surgery; 1994 Dec; 116(6):1118-21; discussion 1121-2. PubMed ID: 7985096 [TBL] [Abstract][Full Text] [Related]
9. Comparison of labeled MIBG and somatostatin analogs in imaging neuroendocrine tumors. Lastoria S; Maurea S; Vergara E; Acampa W; Varrella P; Klain M; Muto P; Bernardy JD; Salvatore M Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):145-9. PubMed ID: 9002775 [TBL] [Abstract][Full Text] [Related]
10. In-111 octreotide scan in a case of a neuroendocrine tumor of unknown origin. Fuster D; Navasa M; Pons F; Vidal-Sicart S; Mateos JJ; Lomeña F; Rodes J; Herranz R Clin Nucl Med; 1999 Dec; 24(12):955-8. PubMed ID: 10595476 [TBL] [Abstract][Full Text] [Related]
11. A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analog (Tyr-3-octreotide) in metastatic carcinoid tumors. Bomanji J; Mather S; Moyes J; Ellison D; Grossman A; Britton KE; Besser GM J Nucl Med; 1992 Jun; 33(6):1121-4. PubMed ID: 1597726 [TBL] [Abstract][Full Text] [Related]
12. Carcinoid tumors: CT and I-131 meta-iodo-benzylguanidine scintigraphy. Adolph JM; Kimmig BN; Georgi P; zum Winkel K Radiology; 1987 Jul; 164(1):199-203. PubMed ID: 3588904 [TBL] [Abstract][Full Text] [Related]
13. [Contribution of 131I MIBG scintigraphy in the diagnosis of carcinoid tumors of the digestive tract. Experience of 14 cases]. Siproudhis L; Lescouarc'h J; Bretagne JF; Bourguet P; Raoul JL; Etienne PL; Herry JY; Gosselin M Gastroenterol Clin Biol; 1991; 15(11):789-93. PubMed ID: 1769467 [TBL] [Abstract][Full Text] [Related]
14. L-3-[123I]Iodo-alpha-methyltyrosine scintigraphy in carcinoid tumors: correlation with biochemical activity and comparison with [111In-DTPA-D-Phe1]-octreotide imaging. Jager PL; Meijer WG; Kema IP; Willemse PH; Piers DA; de Vries EG J Nucl Med; 2000 Nov; 41(11):1793-800. PubMed ID: 11079485 [TBL] [Abstract][Full Text] [Related]
16. [Role of 131I-metaiodobenzylguanidine scintigraphy in the diagnosis of intestinal carcinoids]. Bihl H; Sautter-Bihl ML; Wilhelm KR; Kimmig B Nuklearmedizin; 1987 Dec; 26(6):263-7. PubMed ID: 3438170 [TBL] [Abstract][Full Text] [Related]
17. I-123 MIBG imaging of metastatic carcinoid tumor from the rectum. Watanabe N; Seto H; Ishiki M; Shimizu M; Kageyama M; Wu YW; Nagayoshi T; Kamisaki Y; Kakishita M Clin Nucl Med; 1995 Apr; 20(4):357-60. PubMed ID: 7788995 [TBL] [Abstract][Full Text] [Related]
18. Therapy of neuroendocrine tumors with radiolabeled MIBG and somatostatin analogues. Wiseman GA; Kvols LK Semin Nucl Med; 1995 Jul; 25(3):272-8. PubMed ID: 7570046 [TBL] [Abstract][Full Text] [Related]
19. 111In-pentetreotide and 123I-MIBG for detection and resection of lymph node metastases of a carcinoid not visualized by CT, MRI or FDG-PET. Yüksel M; Eziddin S; Ladwein E; Haas S; Biersack HJ Ann Nucl Med; 2005 Oct; 19(7):611-5. PubMed ID: 16363628 [TBL] [Abstract][Full Text] [Related]
20. Value of somatostatin receptor scintigraphy for preoperative localization of carcinoids. Kisker O; Weinel RJ; Geks J; Zacara F; Joseph K; Rothmund M World J Surg; 1996 Feb; 20(2):162-7. PubMed ID: 8661812 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]